Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $516.0000 (0.63%) ($510.2000 - $518.1990) on Thu. May. 21, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 76 | Latest Price | $516.0000(0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1% a day on average for past five trading days. | Weekly Trend | REGN advances 3.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(37%) XBI(36%) QQQ(31%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -0.86% in a week (0% probabilities). VIXM(-12%) TLT(-6%) SHY(-3%) UUP(-2%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $503.73(2.44%) | 10 Day Moving Average | $493.39(4.58%) | 20 Day Moving Average | $481.93(7.07%) | To recent high | 0% | To recent low | 25.1% | Market Cap | $54.711b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |